Hypertension: The French Medicines Agency Recalls Batches of Drugs Based on Irbesartan
A month and a half after the Valsartan drug recall, irbesartan is also being recalled by the French Medicines Agency on Friday, January 11th. The presence of two substances classified as “carcinogenic” is the cause. After valsartan , another anti hypertensive drug is affected by batch recalls because of the presence of a substance classified as a probable […]
Continue Reading